IMM-02, a novel tubulin targeting agent, collapses the tumor microtube network in primary and recurrent patient derived glioblastoma cell lines to inhibit neurosphere invasion and survival

IMM-02, a Novel Tubulin Targeting Agent, Collapses the Tumor Microtube Network in Primary and Recurrent Patient Derived Glioblastoma Cell Lines to Inhibit Neurosphere Invasion and Survival